Microfluidics Market Research Report

Text-only Preview

Microfluidics Market worth $3.5 Billion by 2018
The "Microfluidics Market Materials (Polymers, Silicon, Glass), Pharmaceuticals
(Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis)
Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends &
Forecast to 2018" analyzes and studies the major market drivers, restraints, and
opportunities in North America, Europe, Asia, and Rest of the World
Browse 72 market data tables and 55 figures spread through 258 pages and in-
depth TOC on "Microfluidics Market Materials (Polymers, Silicon, Glass),
Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic &
Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD
(POC) - Global Trends & Forecast to 2018"
http://www.marketsandmarkets.com/Market-Reports/microfluidics-market-1305.html
Early buyers will receive 10% customization on reports.
This report studies the global microfluidics market over the forecast period of 2013 to
2018.
The global microfluidics market is valued at $1.59 billion in 2013 and is poised to reach
$3.57 billion by 2018, at a CAGR of 17.6%.
The microfluidics market is categorized based on materials, products, and applications.
The polymers market (in the materials segment) and in-vitro diagnostics market (in the
products segment) are considered as potential market segments. The rising demand for
POC diagnostic devices, quick return on investments provided by microfluidic devices
which helps in cost reduction, and miniaturization of microfluidic chips are the major
drivers for this market. The polymers market commands the largest share of the
microfluidics materials market in 2013 and is expected to grow at a healthy CAGR of
more than 20% during the study period. The growth in the adoption rate of polymers by
manufacturers, which is driven by favorable properties of polymers such as enhanced
mechanical strength, optical transparency, chemical stability, biocompatibility, reduced
costs, enhanced profit margins, and extended applications, is the major driver for this
market.
The in-vitro diagnostics segment of the microfluidic products market commands the
largest share and is expected to grow at a healthy CAGR in the next five years. The
large share of this segment can be attributed to the increased adoption of microfluidics
in IVD by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton

Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.). The
various advantages offered by microfluidics are reduced reagent consumption, quick
analysis, and enhanced accuracy of test results. The microfluidics clinical diagnostics
market within the IVD segment is estimated to witness the strongest growth from 2013
to 2018. Enhanced applications in diagnostics such as microfluidic flow cytometry and
cell surface markers are driving the growth of this market.
The drug delivery devices market is expected to grow at the highest CAGR during the
study period. The increasing use of microneedles and micropumps driven by the
enhanced efficacy of drug delivery are the significant drivers of the market growth. Micro
pumps offer various advantages such as low sample consumption, which leads to cost
reduction. This is one of the major factors driving the growth of this market. The
micropumps market within the drug delivery devices segment is estimated to grow at
the highest CAGR from 2013 to 2018.
The Point-of-Care diagnostics applications segment accounts for the largest share of
the microfluidics applications market in 2013 and is expected to grow at a CAGR of
more than 20% during the study period. A number of factors such as the growing
demand for carrying out medical tests at or near the site of patient care in hospitals or at
home, low consumption of samples and reagents, miniaturization of devices, and faster
time of analysis are driving the growth of the POC diagnostics market.
North America accounts for the largest share of the global market in 2013. However, the
Asian region is expected to grow at a higher CAGR in the forecast period. A number of
factors such as lower labor and raw material costs, and growth in investments due to
favorable economic conditions (especially in China and India) are responsible for the
high growth of the microfluidics market in Asia.
Major players in the market include Abbott Laboratories (U.S.), Agilent Technologies
(U.S.), Caliper Life Sciences (PerkinElmer) (U.S.), Cepheid (U.S.), Danaher Corporation
(U.S.), Life Technologies Corporation (U.S.), and Roche Diagnostics (Germany). A
majority of companies in the microfluidics market are from the U.S.
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the
U.S. We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. They cover thirteen industry verticals, including advanced
materials,
automotives
and
transportation,
banking
and
financial
services,
biotechnology, chemicals, consumer goods, energy and power, food and beverages,
industrial
automation,
medical
devices,
pharmaceuticals,
semiconductor
and
electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository. To know more about us
and our reports, please visit our website www.marketsandmarkets.com
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: [email protected]